| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |